Elle MD
Develops a non-hormonal, easily removable birth control ring intended to offer an alternative to hormone-based contraceptives.
Overview
Elle MD is a medical device company developing a non-hormonal birth control ring designed to be easily removable. The product targets people seeking contraceptive options that do not rely on hormones and may offer more user control than some existing methods. The company raised about $1 million in an undisclosed round announced in July 2026 to support development of the ring. While listed under AI in the source data, the described product is a contraceptive health device rather than an AI technology.
Funding History
Elle MD raises $1.1 million to develop non-hormonal, easily removable birth control ring
Frequently Asked Questions
- How much has Elle MD raised in total?
- Elle MD has raised a total of $1M across 1 funding round.
- What does Elle MD do?
- Elle MD is a medical device company developing a non-hormonal birth control ring designed to be easily removable. The product targets people seeking contraceptive options that do not rely on hormones and may offer more user control than some existing methods. The company raised about $1 million in an undisclosed round announced in July 2026 to support development of the ring. While listed under AI in the source data, the described product is a contraceptive health device rather than an AI technology.
- Where is Elle MD headquartered?
- Elle MD is headquartered in San Francisco, CA.
Related Insights
A comprehensive analysis of Isembard's funding history, investors, competitive position, and growth trajectory in the Deep Tech space.
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
395 AI funding deals worth $337B tracked in 2026. Complete guide to raising pre-seed, seed, Series A/B/C+ for AI startups. Valuations, metrics VCs demand, top investors (Sequoia, a16z, Lightspeed), and how AI funding differs from traditional tech. Includes real deal sizes, timelines, and founder strategies.